Skip to content

查尔斯河实验室

US · CRL #1174 按市值排名 上市于 1970
300.15 -6.09 -1.99%
实时 - 追踪5344个代码 - 心跳于418秒前 · 2026-10-16 19:30

✦ 量化股权信号 计算方式说明

增持
  • 最近一期(2026/Q3)披露持股的机构数量减少了1家。
  • 机构持股总比例上升了1.5个百分点。

机构持股

机构持股比例
122.06% +1.51pp
机构数量
679 -1
数据截至
2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期增持了股份,同时该股在最近20个交易日的主力资金呈净流入——两者方向一致。

机构持股变动数据按季度发布且存在滞后;资金流向数据为每日更新。请将其作为方向性的交叉验证参考,而非精确的择时信号。

持股人类型

Mutual Fund105.21%
Hedge Fund8.46%
Public Company4.17%
Government Pension Fund1.38%
Private Company1.07%
Individual/Insider0.99%
Sovereign Wealth Fund0.78%
VC/PE Fund0.30%
Insurance Company0.27%
Family Office/Trust0.24%

主要股东 截至 2026-08-31

FMR 10.10% · 4.82M 股
BlackRock 7.96% · 3.80M 股
Vanguard Capital Management, LLC 7.16% · 3.42M 股
Harris Associates L.P. 4.69% · 2.24M 股
Vanguard Portfolio Management, LLC 4.63% · 2.21M 股
Allspring Global Investments, LLC 3.99% · 1.91M 股
State Street Global Advisors 3.91% · 1.86M 股
Invesco Ltd. 3.88% · 1.85M 股
Dimensional Fund Advisors 3.45% · 1.65M 股
Ariel Investments, LLC 3.16% · 1.51M 股

条形长度是相对于此处列出的最大股东而言,并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 19次买入 · 31次卖出

姓名职务持股比例
James Foster Chairperson & CEO 0.42%
Birgit Girshick Corporate Executive VP & COO 0.12%
Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment 0.09%
Robert Bertolini Independent Director 0.07%
Glenn Coleman Corporate Executive VP & CFO 0.06%
Victoria Creamer Corporate Executive VP & Chief People Officer 0.04%
Martin MacKay Director 0.03%
Joseph LaPlume Corporate Executive Vice President of Corporate Development & Strategy 0.03%
Richard Wallman Independent Director 0.02%
Flavia Pease Corporate Executive VP & CFO 0.01%
Deborah Kochevar Independent Director 0.02%

内部人交易 最近的 Form 4 申报记录

日期姓名职务类型股数价格
2026-10-04 Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment Intent to Sell (Form 144) -981 $314.56
2026-09-29 Glenn Coleman Corporate Executive VP & CFO Open Market Acquisition +10 $297.43
2026-08-24 James Foster Chairperson & CEO Derivative Exercise and Sale -33,561 $194.12–300.00
2026-08-18 Birgit Girshick Corporate Executive VP & COO Other Disposition -528 --
2026-08-18 Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment Derivative Exercise and Sale -2,039 $194.12–294.12
2026-08-17 Nancy Andrews Independent Director Derivative Exercise and Sale -573 $164.30–285.24
2026-08-10 Birgit Girshick Corporate Executive VP & COO Derivative Exercise and Sale -6,500 $179.66–279.90
2026-08-10 Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment Derivative Exercise and Sale -3,714 $179.66–279.66
2026-08-09 James Foster Chairperson & CEO Derivative Exercise and Sale -28,733 $179.66–275.00
2026-08-09 Joseph LaPlume Corporate Executive Vice President of Corporate Development & Strategy Other Disposition -257 --
2026-08-05 Michael Knell Corporate Senior VP & Chief Accounting Officer Open Market Disposition -4,300 $259.07–265.17
2026-08-05 Michael Knell Corporate Senior VP & Chief Accounting Officer Derivative Exercise and Sale -2,345 $179.66–258.53
2026-08-05 Victoria Creamer Corporate Executive VP & Chief People Officer Derivative Exercise and Sale -4,179 $179.66–259.16
2026-08-04 Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment Open Market Disposition -5,046 $263.00
2026-06-28 James Foster Chairperson & CEO Open Market Disposition -75,000 $225.00
2026-06-04 James Foster Chairperson & CEO Other Acquisition +183,361 --
2026-06-04 James Foster Chairperson & CEO Other Disposition -183,361 --
2026-06-04 Birgit Girshick Corporate Executive VP & COO Other Acquisition +3,386 --
2026-06-04 Birgit Girshick Corporate Executive VP & COO Other Disposition -3,386 --
2026-06-04 Shannon Parisotto Corporate Executive Vice President of Global Discovery & Safety Assessment Other Acquisition +1,529 --

Form 4 申报记录,每家公司显示最新的一批。"Other Derivative Acquisition"(其他衍生品获取)类目多为限制性股票/期权归属,并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:05 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

查尔斯河实验室 讨论区 0 条评论

发表评论